Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 18 Aug 2026 for Lexeo Therapeutics, Inc., €17k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
No signal scores available.
Tamayo Louis Edward: trading record in brief
This profile gathers the share dealings of Tamayo Louis Edward in Lexeo Therapeutics, Inc. Over a trading history stretching from 1 July 2026 to 18 August 2026, the count stands at 2 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 18 August 2026, the filings show a transaction worth €17k in Lexeo Therapeutics, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Tamayo Louis Edward
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations2 total
4,117 shares@ US$4.9071CommonSEC144:0001959173-26-006152
4,641 shares@ US$4.4850.0057% mcap100.0% of flowCommonSEC144:0001959173-26-005033
2 of 2 declarations
